Midterm Outcomes in an Expanded Cohort of Harmony Transcatheter Pulmonary Valve Recipients
Brian H. Morray, M.D.1, Matthew J. Gillespie, M.D., FSCAI2, John P. Cheatham, MD, MSCAI3, Arash Salavitabar, M.D., FSCAI4, Lynn F. Peng, M.D., FSCAI5, Thomas K. Jones, M.D., MSCAI1, Daniel S. Levi, M.D., FSCAI6, Robert G. Gray, M.D.7, Jeremy D. Asnes, M.D.8, Allison K. Cabalka, M.D., FSCAI9, Kazuto Fujimoto, MD10, Athar M. Qureshi, M.D., FSCAI, FSCAI11, Lisa Bergersen, M.D., MPH12, Lee N. Benson, M.D., MSCAI13, Daniel Haugan14 and Doff B. McElhinney, M.D., FSCAI15, (1)Seattle Children’s Hospital, Seattle, WA, (2)Children's Hospital of Philadelphia, Philadelphia, PA, (3)The Ohio State University, Columbus, OH, (4)Nationwide Children's Hospital, Columbus, OH, (5)Stanford University, Palo Alto, CA, (6)David Geffen School of Medicine at UCLA, Pacific Palisades, CA, (7)The University of Utah, Salt Lake City, UT, (8)Yale University, New Haven, CT, (9)Mayo Clinic Health System Rochester, Rochester, MN, (10)National Cerebral and Cardiovascular Center, Suita city, Japan, (11)Texas Children's Hospital, Bellaire, TX, (12)Children's Hospital Boston, Boston, MA, (13)The Hospital for Sick Children, Toronto, ON, Canada, (14)Medtronic, Minneapolis, MN, (15)Stanford University Medical Center, Stanford, CA